Efficacy of jalokavacharna(leech therapy) by Raktamokshan(blood letting) in Androgenic Alopecia (baldness)

A Clinical Study On Efficacy of Raktamokshan by Jalaukavacharna in Khalitya w. S.r Androgenic Alopecia - No

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032909

Enrollment

Registered

2021-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Raktamokshan by leeches: Informed written consent will be taken from the patients.Under aseptic condition as required leeches will be applied on the scalp region in four sitting once in

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients age between 20-50 yrs irrespective of sex, caste & religion will be. 2. Willing patient for treatment will be including. 3. Patients presenting with Androgenic (Hair loss on scalp) will be selected for study. 4. Patients Fit for Jalaukavacharna.

Exclusion criteria

Exclusion criteria: 1. Below 20 years and above 50 years. Patients will be excluded. 2. HIV infected patients, Infection disease 3. Patient on immune suppressive drugs. 4. Anaemic patients. 5. Pregnant ladies. 6. Patients on chemotherapy.

Design outcomes

Primary

Measure	Time frame
Growth of new hair follicles Minimization of hair lossTimepoint: 7th week 14th week 21th week and 28th week	—

Secondary

Measure	Time frame
minimization of itching,roughness,and dandruffTimepoint: 7th day,14th day and 21th day	—

Countries

India

Contacts

Public ContactSHALU

SHRI KRISHNA GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL, KURUKSHETRA

ayurvedgoa@gmail.com9729092181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026